CIK 0001938046 · <br>Emerging growth company
MANGOCEUTICALS, INC.
Sign in to watch- Ticker
- MGRX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 873841292
- Phone
- (833) 626-4679
- Business address
- 15110 DALLAS PKWY, SUITE 600, DALLAS, TX, 75248
- Former names
- MANGOCEUTICALS, INC.
- 4 Grant or award Chief Executive Officer acquired 2,000,000 shares (grant or award)
- 4 Grant or award CFO acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 500,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CFO sold 3,333 shares at $1.17 ($3,884)
- 4 Open-market sale CFO sold 5,000 shares at $1.20 ($5,975)
- 4 Open-market sale CFO sold 10,000 shares at $1.13 ($11,280)
- 4 Open-market sale Director sold 125,000 shares at $1.22 ($152,875)
- 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award President acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 1 of 2 · 39 filings